Daridorexant to prevent delirium after heart surgery
Official title: Randomized, Double-blind Trial of Daridorexant to Prevent Delirium After Heart Surgery
Run by University of Rochester · NCT07217912 · Data updated 2026-11-12
This study will test whether taking daridorexant the first three nights after heart surgery can reduce postoperative delirium and improve sleep in people aged 60 and older.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Drugs / interventions | ceritinib |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | October 14, 2025 |
| Main results expected | November 1, 2027 |
| Study ends | November 1, 2027 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT07217912 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 60 or older having surgical aortic valve replacement or coronary artery bypass grafting at the University of Rochester's Strong Memorial Hospital who can consent and complete English-language assessments.
✕Probably not a fit
Patients with baseline delirium or dementia-level cognitive impairment, those undergoing emergency or repeat cardiotomy, people with severe liver or kidney dysfunction, or those taking contraindicated medications or regular prescription sleep aids are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, placebo-controlled pilot trial of daridorexant 50 mg given each of the first three nights after surgical aortic valve replacement or coronary artery bypass grafting. Participants complete a baseline visit, receive daridorexant or placebo in the hospital, and are evaluated daily for delirium symptoms and sleep during the first three postoperative days. The protocol includes an optional wrist-worn sleep monitor to collect objective sleep data in the postoperative setting. The trial follows a prior feasibility effort and is intended to generate preliminary effect estimates to plan a larger phase 2b trial.
Why it matters
Potential benefit: If successful, the drug could reduce the incidence and severity of postoperative delirium and improve sleep quality after cardiac surgery.
How similar studies have gone: Using an orexin receptor antagonist to prevent postoperative delirium is a novel application, though a prior feasibility study at the same center supported conducting this randomized pilot and daridorexant is already approved for treating insomnia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 60 yrs; * having surgical aortic valve surgery or coronary artery bypass graft surgery at Strong Memorial Hospital; * can provide consent; * able to speak, read,and write English (as the instruments, including semi-structured interviews, used in this protocol have been validated in English); * family member or close friend for collateral. Exclusion Criteria: * Prior cardiotomy * Infectious endocarditis * Emergency surgery * Delirium at baseline (positive 3D-CAM) * Auditory or visual impairment that prevents study procedures * Alcohol or substance misuse (CAGE-AID score ≥ 2) * Psychotic disorder * Dementia-level deficits (TICS \< 27) * Use of a prescription sleep aid at least every other night * Use of a strong CYP3A4 inhibitor (e.g., ceritinib, clarithromycin, cobicistat, idelalisib, itraconazole, ketoconazole, nefazodone, nelfinavir, posaconazole, ritonavir, telithromycin, voriconazole) * Daridorexant intolerance * Severe kidney or liver impairment (Child-Pugh ≥7, Cockcroft-Gault \<30 mL/min, or on dialysis) * Narcolepsy * Suicidal ideation at baseline * Any condition that, in the PI's opinion, compromises patient safety or data quality * Additional exclusions for the NLP exploratory aim: history of traumatic brain injury or head concussions with loss of consciousness, use of corticosteroids, or history of major neurological disease or brain surgery
Where it's running
-
University of Rochester Medical Center
Rochester, New York, United States Recruiting
Study contacts
- Study coordinator: Mark Oldham, MD
- Email: mark_oldham@urmc.rochester.edu
- Phone: 585-275-3592
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive training to prevent cognitive decline after heart surgery
This study is testing if doing brain exercises before heart surgery can help prevent memory problems and confusion after the surgery for patients undergoing elective cardiac procedures.
-
Intranasal insulin to reduce delirium after heart surgery with a heart-lung machine
This study tests whether giving intranasal insulin can reduce glycemic swings and delirium after elective heart surgery with cardiopulmonary bypass.
-
Postoperative Pain Control in Elderly Knee Replacement
This study tests two pain-management methods after knee replacement in adults 60 and older to see which one reduces delirium and improves recovery.
-
Perioperative transcranial photobiomodulation to see if it helps older adults recover brain function after surgery
This trial tests whether applying light therapy to the brain around the time of surgery can reduce delayed brain recovery in older patients with pre-existing cognitive decline.
-
Risk of delirium and cognitive problems after TUR-P in older adults
This study tests whether certain perioperative factors can predict delirium and postoperative cognitive dysfunction in people aged 65 and older undergoing transurethral resection.
-
How anesthesia type affects thinking after bariatric sleeve surgery
This observational study tests whether intravenous anesthesia or inhalational anesthesia leads to different cognitive outcomes after sleeve gastrectomy in adults with obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.